There are many good reasons to invest and work in the life science sector in the Oslo region.
- Internationally renowned research environments
- Strong industrial tradition with cross-fertilisation
- A diverse red, blue and green biotech sector
- Access to the most highly educated workforce in Europe
- A sophisticated public healthcare market
- Steadily increasing state funding for R&D
- An enterprise-friendly regulatory atmosphere and solid private-public collaboration
- Infrastructural strengths in health registers and clinical testing
- Public support for medical and pharmacological innovation
See testimonials from people working here:
"We have freedom to innovate here quite unlike anywhere else. For high quality studies with near 100% follow-up guaranteed, Oslo is unrivalled".
Erik Fosse,
Head of the Interventional Center, Rikshospitalet
"The strong neuroscience tradition in Oslo, dating back to early in the last century and represented today by many excellent laboratories at a number of institutions, is helping my group and others create an internationally competitive neuroscience research community here".
Joel Glover
Research Team Leader,
Department of Physiology, Institute of Basic Medical Sciences, University of Oslo
"In Oslo you have access to top international competence in critical disciplines. This means access to both permanent employees and the necessary consultants. Proximity to investors and the Oslo Stock Exchange means easier access to capital, and makes follow-up of investors easier."
Bernt Olav Røttingsnes,
CFO, Navamedics
"Norway and the Oslo region have made pivotal academic and commercial contributions in revolutionizing estab¬lished practices in global aquaculture, particularly in the industrialisation of major species."
Øystein Lie,
Founder GenoMar
"When AstraZeneca analysed cancer research environments around the world for collaboration potential on clinical trials, they found the environment in Oslo to be among the best in the world".
Christian Clemm
Medical Director, AstraZeneca Norway
"Oslo is a good place for people with higher technical education. The labour market is strong, and Oslo has one of Europe's most attractive biotech clusters, including university hospitals such as Rikshospitalet-Radiumhospitalet and Ullevaal."
Martin Welshof,
CEO Affitech
"Oslo and Norway show the fastest implementation of new pharmaceutical therapies of any country in Scandinavia, and Oslo is an ideal location to execute clinical trials".
Henrik Lund,
Global Vice President, Clinical Development, AstraZeneca
"Oslo gave me better position than before, a clear financial package for five years including necessary instrumentation, and the opportunity to be part of the development of an institute and to build up my own groups".
Bernd Thiede
(formerly of the Max Planck Institute in Berlin)
Group Leader, proteomics research group,
The Biotechnology Centre of Oslo
"We have been able to build something exciting from scratch – this is what everybody dreams of. The standard of Norwegian biomedical research has skyrocketed in the last years. Oslo is a good place for biotech. A lot is going to happen in the coming years."
Stefan Krauss
Research Team Leader, Cellular and Genetic Therapy Research Group
Norwegian Center for Stem Cell Research